Evidence map›Paper›PMID 32823398›Full record

ReviewIndian journal of ophthalmology2020

Scleritis: Differentiating infectious from non-infectious entities.

Somasheila I Murthy, Swapnali Sabhapandit, S Balamurugan, Pranesh Subramaniam, Maite Sainz-de-la-Maza, Manisha Agarwal, Carlos Parvesio

Open access · diamondAbstract readReview
In one paragraph

Review in Indian journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Update on Therapy for Non-Infectious Scleritis.Clinical ophthalmology (Auckland, N.Z.) · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Demystifying nocardial scleritis.BMJ case reports · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Exploring a New Era in Uveitis.Indian journal of ophthalmology · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Somasheila I MurthyThe Cornea Institute, L V Prasad Eye Institute, Hyderabad, Telangana, India.
Swapnali SabhapanditNeoRetina Eye Care Institute, Centre for Sight, Hyderabad, Telangana, India.
S BalamuruganDepartment of Uvea, Aravind Eye Hospital, Pondicherry, India.
Pranesh SubramaniamDepartment of Uvea, Aravind Eye Hospital, Pondicherry, India.
Maite Sainz-de-la-MazaHospital Clinic of Barcelona, Spain.
Manisha AgarwalDr. Shroff's Charity Eye Hospital, New Delhi, India.
Carlos ParvesioConsultant Ophthalmologist, Moorfields Eye Hospital, Senior Lecturer, Biomedical Research Centre, Institute of Ophthalmology UCL Moorfields Eye Hospital, London, United Kingdom.
L V Prasad Eye Institute · INDr. Shroff’s Charity Eye Hospital · INHospital Clínic de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scleritis is a rare painful ocular disorder, associated with severe ocular pain and tissue destruction. Although a majority of these cases are immune mediated and at least half of these are associated with systemic immune-mediated diseases, a smaller minority are due to infections of the sclera. The two conditions closely mimic each other, and a thorough knowledge of the subtle differences is necessary in order to reach a timely diagnosis. Diagnostic delay can lead to a poor outcome both due to the destruction caused by the uncontrolled infection and also due to propagation of the infection with the use of corticosteroids which may have been started for presumed immune mediated scleritis. In this review, we present the clinical features, etiological agents, and the differentiating features between immune and infectious scleritis. We also present diagnostic and management guidelines for managing scleral infection.

Indexed as

ScleritisAdrenal Cortex HormonesDelayed DiagnosisEye PainHumansScleraAdrenal Cortex HormonesFungal scleritisimmune mediated scleritisinfectious scleritismanagement of infectious scleritisscleral debridementtubercular scleritis

Identifiers

PMID32823398
PMCPMC7690484
OpenAlexW3081369897

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.